POMC and neoplasm: Serotonin antagonists, particularly cyproheptadine, have been proposed as a possible pharmacological agent for the suppression of ACTH in patients with NS through a potential hypothalamic action and/or a direct effect on ACTH-secreting tumour cells [55].